RHO and cancer: On the other hand, confirming the relevance of RHO modulatory activity on developmental signaling also for cancer, mutations in RHOA have been recently linked to B-cell lymphoma and Burkitt lymphoma via impaired PI3K pathway (Svensmark and Brakebusch, 2019; Voena and Chiarle, 2019).